| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Apr 1, 2024 | Apr 3, 2024 | Beam Therapeutics Inc. | CFO | Sell | 32.5 | -5,446 | -7.21% | ✓ | $174.9K |
| Jul 12, 2023 | Jul 14, 2023 | RECURSION PHARMACEUTICALS, INC. | Director | Sell | 5.0 | -117,000 | -68.08% | ✓ | $1.4M |
| Apr 3, 2023 | Apr 5, 2023 | Beam Therapeutics Inc. | CFO | Sell | 28.8 | -4,640 | -8.96% | ✓ | $138K |
| Jan 26, 2023 | Jan 30, 2023 | Beam Therapeutics Inc. | CFO | Sell | 5.0 | -37,254 | -37.33% | ✓ | $1.7M |
| Jan 23, 2023 | Jan 25, 2023 | Beam Therapeutics Inc. | CFO | Sell | 12.5 | -20,236 | -24.44% | ✓ | $910.9K |
| Jan 18, 2023 | Jan 20, 2023 | Beam Therapeutics Inc. | CFO | Sell | 5.0 | -47,195 | -60.14% | ✓ | $2.1M |
| Mar 31, 2022 | Apr 4, 2022 | Beam Therapeutics Inc. | CFO | Sell | 95.0 | +13,213 | 52.71% | ✗ | $105.6K |
| Jun 30, 2021 | Jul 2, 2021 | Beam Therapeutics Inc. | CFO | Sell | 5.0 | -30,000 | -54.74% | ✓ | $3.7M |
| Jun 28, 2021 | Jun 30, 2021 | Beam Therapeutics Inc. | CFO | Sell | 5.0 | -45,000 | -64.46% | ✓ | $4.8M |
| Jan 4, 2021 | Jan 5, 2021 | Beam Therapeutics Inc. | CFO | Sell | 5.0 | -25,000 | -77.38% | ✓ | $2M |